secwatch.observer — SEC 8-K summary
======================================

Issuer:     EyePoint, Inc. (EYPT)
CIK:        0001314102
Form:       8-K
Filed at:   2021-11-01T23:59:59+00:00
Accession:  0001564590-21-053039
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EyePoint appoints Jay S. Duker as COO; $500K base, 305K options
---------------------------------------------------------------

- Appointed Jay S. Duker, M.D. as COO effective Nov. 1, 2021; he had served as part-time Chief Strategic Scientific Officer since July 2020.
- Annual base salary of $500,000; eligible for target annual bonus of 50% of base salary based on performance.
- Granted options to purchase 305,000 shares at $11.47, vesting over 4 years; received 15,258 RSUs valued at $175,000 vesting in 1 year.
- Received one-time cash award of $175,000 subject to repayment if terminated for cause within one year.
- Dr. Duker previously chaired ophthalmology at Tufts Medical Center and co-founded three start-ups including Hemera Biosciences.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314102/000156459021053039/0001564590-21-053039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314102/000156459021053039/eypt-8k_20211101.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-053039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer